MRD / Regn No. : THBC\23-24\02258 Date : 30/06/2026
Patient Name : Murti Devi Age & Gender : 66 Yrs. / Female
Contact No. : 9876671105 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Subjective : T2DM- 12YRS,CATARACT SURGERY DONE IN FEB 2023,OCTOBER HBA1C 6% - NOW 7%,LAST HBA1C-7%,RE MOD NPDR / LE MILD NPDR
Objective : 17-JUN-2026 REPORTS,HB-12.8/ HBA1C-7.14,FBS-170/ PPBS-180,TC-131/ TG-150/ LDL-46.4/ HDL-54.6,ALT-31/ AST-24.3,T3-169/ T4-9.78/ TSH-3.84,CR-0.7,EGFR-89.40,ACR-187.98
Plan : SINCE NPDR DETECTED FIRST TIME - RECHECK IN 6 MTHS AS SINCE LAST 3 YRS - SUGAR VERY WELL CONTROLLED  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET GLIMEPIRIDE 0.5 MG + METFORMIN 500 MG
GLIMISAVE M 0.5
ORAL 1-0-1 BBF/BD
6 MTHS
2 JALRA DP 10/100 MG ORAL 1-0-0 30 MINS BBF
6 MTHS
3 CCM ORAL 0-1-0 3 DAYS A WEEK
6 MTHS
4 DRISE 60,000 ORAL ONCE A MONTH ANYTIME
6 MTHS
5 NERVIHENZ ORAL 0-1-0 AL
6 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 14/Dec/2024
Tests Suggested For Next Visit : HBA1C / FBS / PPBS > 6 MTHS,RETINA RECHECK 6 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: